Biochemical Reagent
-
BA2315 PolatuzumabSummary: Polatuzumab is a monoclonal antibody with a chemotherapeutically active molecule. -
BA2316 InotuzumabSummary: Inotuzumab (HumanizedAnti-CD22RecombinantAntibody) is humanized, κ-antibody targeted to humans. -
BA2317 IzeltabartSummary: Izeltabart is a high affinity humanized antibody that targets. -
BA2318 LifastuzumabSummary: Lifastuzumab is a humanized anti-monoclonal antibody (IgG1 type). -
BA2319 BriobaceptSummary: Briobacept (BR3FC) is a selectively targeted monoclonal antibody that induces apoptosis in B cells. -
BA2320 DxdSummary: Dxd (ExatecanderivativeforADC) is a potent inhibitor. -
BA2321 MertansineSummary: Mertansine (DM1) is an inhibitor and an antibody-conjugatable medetomidine alkaloid used to overcome the systemic toxicity associated with medetomidine and to enhance tumor-specific delivery. -
BA2322 ExatecanSummary: Exatecan (DX-8951) is a DNA topoisomerase I inhibitor. -
BA2323 DM4Summary: DM4 is an anti-microtubule protein agent that inhibits cell division. -
BA2324 SG3199Summary: SG3199 is a cytotoxic DNA minor groove interstrand cross-linked PBD dimer.

